Biohaven steps up big clinical plans for its reformulated ALS generic — now also aimed at anxiety
Biohaven $BHVN put together a tiny test study to see if their drug BHV-0223 — a reformulation of an old ALS drug called riluzole — could tackle …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
